Cardiac enzyme tests are blood tests that detect heart muscle injury. Key markers: cardiac troponins (I and T) — the most specific; CK-MB (creatine kinase‑MB); myoglobin (early but nonspecific); creatine kinase (total CK); and lactate dehydrogenase (LDH) isoenzymes. These are used to diagnose and time myocardial infarction and monitor cardiac damage.

Common cardiac enzyme reference ranges for adults: - Troponin I (high‑sensitivity): <0.04 ng/mL (or <40 ng/L) - CK‑MB (mass): <5 ng/mL (or <5% of total CK) - Myoglobin: usually <90 ng/mL (typical 0–85 ng/mL) Values vary by assay and laboratory; always compare to your lab’s specific reference interval and consult a clinician for interpretation.

Cardiac troponins (troponin I and T) are the most important cardiac biomarkers for diagnosing myocardial injury. They are highly specific and sensitive, rising within 3–4 hours after injury, peaking around 12–48 hours, and remaining elevated for up to 7–14 days. High-sensitivity troponin assays improve early detection and risk stratification, making troponin the preferred test for suspected heart attacks.

Another name for a cardiac enzyme is a cardiac biomarker (or cardiac marker). These are proteins—such as troponin, CK‑MB and myoglobin—released into the bloodstream when heart muscle is injured. Measurement of cardiac biomarkers helps diagnose and monitor heart attacks and other cardiac damage, guiding emergency treatment and risk assessment effectively.

Raised cardiac enzymes (like troponin) indicate heart muscle injury—often myocardial infarction. They trigger urgent evaluation (ECG, imaging, possible angiography) and treatments to restore blood flow (antiplatelets, anticoagulants, thrombolysis or PCI) plus monitoring for arrhythmias and heart failure. Enzyme levels help diagnose severity and prognosis; persistently high or rising values suggest ongoing damage and need for hospitalization and cardiac care.

Yes. Severe physical or emotional stress can raise cardiac enzymes, particularly troponin, by causing myocardial injury from coronary ischemia, oxygen demand–supply mismatch, or catecholamine-mediated damage (as in Takotsubo/stress cardiomyopathy). Everyday stress rarely elevates enzymes. Any enzyme rise signals heart injury and requires prompt medical evaluation, especially with chest pain, breathlessness, fainting, or palpitations.